Actuate Therapeutics Inc (ACTU)
R&D Expense Growth
-19.43%
Quarterly · Period ending:
ACTU R&D Expense Growth
Latest reported-19.43%period ending
Latest reported-19.43%period ending
ACTU Quarterly R&D Growth (QoQ) (0.00% → -19.43%)
Latest values, visible window
High-resolution chart · PNG
ACTU r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -19.4297% | |
| 20.4581% | |
| -2.2199% | |
| -21.2269% | |
| -14.145% | |
| -12.6323% | |
| -1.8941% | |
| -14.0803% | |
| -36.2605% | |
| 3.2291% | |
| 15.3488% | |
| 20.6032% | |
| 5.6034% | |
| 0% |